Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States, the United Kingdom, Japan, Germany, Spain, Italy, and France. It offers minimally-invasive endovascular aneurysm repair (EVAR) products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the Ovation abdominal stent graft system. The company also provides endovascular sealing (EVAS) product, the Nellix EVAS system for the treatment of infrarenal abdominal aortic aneurysms; and accessories for use in the treatment of AAA, including compatible guidewires, inflation devices, and snares. It sells its products through direct sales force, distribution agreements, and other arrangements to hospitals and medical centers. The company was founded in 1992 and is headquartered in Irvine, California.